Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas

Figure 2

PCR curves from five separated PCR chambers (A–E) for a serous ovarian carcinoma which tested negatively for NRAS mutation on the Idylla platform (a). Histological specimens from the same tumor, H&E: ×4 (b) and ×10 (c).

(a)

(b)

(c)